Abstract:Malignant melanoma, as a highly aggressive skin cancer, is strongly associated with mutations in serine/threonine protein kinase B-RAF (BRAF, where RAF stands for rapidly accelerated fibrosarcoma). Targeted therapy with anti-BRAF small interfering RNA (siBRAF) represents a crucial aspect of metastatic melanoma treatment. In this study, an injectable hydrogel platform based on sodium alginate (SA), with multifunctions of photothermal and Ca<sup>2+</sup>-overload cell apoptosis, was explored as a siBRAF carrier for metastatic melanoma therapy. We employed polydopamine nanoparticles (PDAs) as a photothermal core and constructed a calcium phosphate (CaP) shell via biomineralization (PDA@CaP) to load siBRAF (PDA@siBRAF/CaP). The pH-sensitive CaP shell facilitated the release of Ca<sup>2+</sup> under the weakly acidic tumor microenvironment, triggering the gelation of PDA@siBRAF/CaP-SA to localized release siBRAF at tumor sites with the interruption of the RAS-RAF-MEK-ERK (MAPK) pathway. Besides, the continuous release of Ca<sup>2+</sup> could also lead to Ca<sup>2+</sup>-overload cell apoptosis. Moreover, the photothermal effect of PDA regulated the release kinetics, resulting in coordinated therapeutic abilities of individual components in the PDA@siBRAF/CaP-SA hydrogels. Consequently, the effective inhibition of tumor growth and metastasis was achieved in vitro and in vivo using a highly metastatic melanoma cell line B16F10 as the model, by combining photothermal ablation, Ca<sup>2+</sup> overload, and BRAF silencing. Our work provides a proof-of-concept for an injectable hydrogel system that simultaneously targets multiple mechanisms involved in melanoma progression and has the potential to be translated into clinical use for the metastatic melanoma therapy.
materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the treatment of malignant melanoma. Specifically, the paper explores an injectable hydrogel platform based on sodium alginate (SA), which combines the multiple functions of photothermal effect, calcium - ion - overload - induced apoptosis, and BRAF gene silencing for the treatment of metastatic melanoma.
### Background of the Paper and Problem Description
**1. Characteristics of Malignant Melanoma**:
- Malignant melanoma is a highly invasive skin cancer with a strong potential for distant metastasis.
- Approximately 60% of melanoma patients have activating mutations in the BRAF gene, which leads to the continuous activation of the RAS - RAF - MEK -ERK (MAPK) signaling pathway, promoting the progression of melanoma and resistance to traditional therapies.
**2. Limitations of Existing Treatment Methods**:
- For BRAF - mutated melanoma, although there are drugs that inhibit BRAF and its downstream targets, the efficacy of these drugs is limited, and there are certain toxic and side effects.
- Small interfering RNA (siRNA), as a gene - silencing tool, can precisely target and inhibit specific genes. For example, siBRAF can silence the BRAF gene, thereby disrupting the regulation of cell growth and differentiation by the MAPK signaling pathway. However, siRNA is easily degraded in vivo and has difficulty crossing the cell membrane, so an effective delivery system is required to improve its therapeutic effect.
**3. New Method Proposed in the Paper**:
- This study has developed an injectable hydrogel platform based on sodium alginate. This platform contains polydopamine nanoparticles (PDAs) as the photothermal core and is coated with a calcium phosphate (CaP) shell layer on its surface through biomimetic mineralization, loading siBRAF (PDA@siBRAF/CaP).
- In the weakly acidic tumor microenvironment, the CaP shell layer of this hydrogel platform will dissolve, releasing Ca2 +, triggering the formation of the hydrogel, and achieving the local release of siBRAF at the tumor site.
- At the same time, the photothermal effect of PDA can regulate the release kinetics of drugs (Ca2 + and siBRAF), coordinating the therapeutic effects of each component, thereby achieving synergistic treatment.
### Main Objectives
- **Effectively Inhibit Tumor Growth and Metastasis**: By combining photothermal ablation, calcium - ion - overload, and BRAF gene silencing, effectively inhibit the highly metastatic melanoma cell line B16F10.
- **Improve the Safety and Efficacy of Treatment**: Through the injectable hydrogel platform, reduce damage to normal tissues and improve the targeting and controllability of treatment.
- **Provide the Potential for Clinical Translation**: This study provides a proof - of - concept for the injectable hydrogel system, demonstrating its potential application value in the treatment of metastatic melanoma.
In conclusion, this paper aims to overcome the limitations of existing treatment methods and achieve effective treatment of malignant melanoma by developing a multifunctional injectable hydrogel platform.